Category: LISTED IPO

Credent Connect N Care

Credent Connect N Care IPO: Complete Analysis, Dates, Financials & Review

Are you looking to invest in the rapidly expanding healthcare logistics sector? The Credent Connect N Care IPO is generating significant interest among market participants. Opening for subscription in mid-August 2026, this SME Initial Public Offering brings an opportunity to partake in a technology-enabled operational and supply chain enterprise.

In this comprehensive guide, we dissect every critical aspect of the Credent Connect N Care IPO. From the core business model and latest financial performance to valuation metrics and investment lot sizes, we provide a holistic overview to help you make an informed decision.

Business Overview: What Does Credent Connect N Care Do?

Originally incorporated in 2015 as Credent Cold Chain Logistics Private Limited, Credent Connect N Care Limited has evolved into a premier integrated healthcare services and logistics provider. The company predominantly operates on a Business-to-Business (B2B) framework, catering to diagnostic labs, pharmaceutical giants, hospitals, and In-Vitro Diagnostics (IVD) companies across India.

Core Operations & Services

Healthcare Logistics: Specialized movement of diagnostic samples, reagents, and medical supplies using temperature-controlled (cold-chain) and time-sensitive transport solutions.
Diagnostic & Paramedical Support: Supplying trained phlebotomists for home sample collections, alongside providing stationed laboratory manpower services.
Technology-Driven Platforms: Leveraging proprietary tech platforms like “C3 Post” for courier aggregation and real-time operational tracking.
Corporate Wellness: Operating under the brand “C3 Wellness,” they conduct health camps, vaccination drives, and preventive check-ups for corporate workforces.

Operating with a robust workforce of 6,338 employees (as of March 2026) and holding ISO 9001:2015 and ISO 15189:2022 certifications, the company has heavily bolstered its market presence through strategic acquisitions like Alltrak Technologies and Credent Healthcare.

Credent Connect IPO Schedule & Timeline

Tracking the critical dates is essential for a smooth application process. The entire bidding to listing cycle is scheduled over a span of a week. Below is the progress tracking of the IPO:

IPO Opens

Aug 13, 2026 (Thu)

IPO Closes

Aug 17, 2026 (Mon)

Allotment

Aug 18, 2026 (Tue)

Refunds/Credit

Aug 19, 2026 (Wed)

Listing Date

Aug 20, 2026 (Thu)

Crucial IPO Issue Details

The company is aiming to raise roughly ₹94 Crores entirely through a fresh issue of shares. Here is the structured breakdown of the offering:

Parameter	Details
Issue Type	Book Built Issue IPO
Face Value	₹10 per equity share
Price Band	₹179 to ₹189 per share
Total Issue Size	49,68,000 shares (Aggregating ₹93.90 Cr)
Fresh Issue Size	49,68,000 shares (Ex-Market Maker: 47.16 Lakh shares)
Listing Exchange	NSE SME
Market Maker Portion	2,52,000 shares

Subscription Lot Size & Investor Allocation

For retail investors and High Net-worth Individuals (HNIs), the capital requirement is defined by the lot sizes. The minimum investment requires bidding for at least one lot.

Lot Size Breakdown

Investor Category	Minimum Lots	Shares Total	Investment Required (₹)
Retail (Min & Max)	2 Lots	1,200 Shares	₹2,26,800
Small HNI (Min)	3 Lots	1,800 Shares	₹3,40,200
Small HNI (Max)	8 Lots	4,800 Shares	₹9,07,200
Big HNI (Min)	9 Lots	5,400 Shares	₹10,20,600

Reservation Quota

QIB (Qualified Institutional Buyers): 49.87% of Net Issue
Retail Individual Investors: 35.11% of Net Issue
NII (Non-Institutional Investors/HNI): 15.01% of Net Issue

Company Financial Performance

A deep dive into the financial statements reveals a massive operational scale-up in the most recent fiscal year. After a steady run in FY24 and FY25, the consolidated figures for FY26 show a dramatic surge in both top-line revenue and bottom-line profit.

Financial Metric (₹ in Crores)	FY 2024 (Standalone)	FY 2025 (Standalone)	FY 2026 (Consolidated)
Total Assets	26.41	29.50	81.57
Total Revenue	76.02	78.23	214.43
Profit After Tax (PAT)	2.66	2.25	18.45
EBITDA	4.30	4.99	28.46
Net Worth	13.66	15.90	43.79
Total Borrowings	6.85	7.42	21.95

Valuation Metrics & Key Performance Indicators

To understand if the IPO is fairly priced, evaluating the company’s Key Performance Indicators (KPIs) based on FY26 earnings is crucial.

Indicator	Value (As of March 2026)
Pre-IPO EPS	₹13.92
Post-IPO EPS (Estimated)	₹10.12
P/E Ratio	13.58x (Pre-IPO) / 18.68x (Post-IPO)
Return on Equity (ROE)	61.81%
Return on Capital Employed (ROCE)	40.00%
Debt to Equity Ratio	0.50
Market Cap at Offer Price	₹344.41 Crores

Objectives of the Issue & Anchor Participation

Capital raised through public markets must have clear deployable goals. Credent Connect N Care has earmarked the net proceeds (approximately ₹72.80 Crores after expenses) for the following core areas:

Working Capital for Company: ₹37.00 Crores allocated to meet standalone operational working capital requirements.
Subsidiary Investments: ₹26.80 Crores for working capital and ₹3.00 Crores for capital expenditure (machinery) infused into their wholly-owned subsidiary, Credent Healthcare Private Limited.
Debt Repayment: ₹6.00 Crores designated to repay or prepay existing corporate borrowings.
General Corporate Purposes: Balance funds utilized for strategic operational enhancements.

Anchor Investor Highlights

Before the public bidding opens, the company successfully raised ₹26.54 Crores from Anchor Investors on August 12, 2026. A total of 14,04,000 shares were allocated, signaling strong early institutional confidence.

SWOT Analysis: Credent Connect N Care

A strategic overview of the company’s internal strengths and external environment:

Strengths

Integrated end-to-end healthcare logistics platform.
Strong technological backbone (C3 Post and C3 HRMS).
Pan-India footprint serving high-profile B2B clients.
Diversified revenue streams (diagnostics, wellness, manpower).

Weaknesses

Heavy reliance on the B2B segment can lead to concentrated client risk.
A sudden, massive spike in FY26 revenues may raise questions regarding long-term margin sustainability.

Opportunities

Increasing demand for specialized cold-chain logistics in the pharma sector.
Expansion scope into Tier 2 and Tier 3 cities across India.
Scaling up the “C3 Wellness” corporate segment in a post-pandemic world.

Threats

Highly competitive landscape with established logistics and diagnostic players.
Strict regulatory environment concerning medical data and sample transportation.

Promoter Holding & Management

A company’s leadership determines its future trajectory. Credent Connect N Care is backed by a robust promoter group comprising Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma, and Tanveen.

Pre-Issue Promoter Holding: 87.64%
Post-Issue Promoter Holding: 63.75%

This post-issue stake indicates that the original founders and promoters retain a commanding majority, aligning their interests with those of retail and institutional shareholders.

Market Analyst View & Final Conclusion

Market analysts note that the company operates in a high-growth niche—healthcare logistics intertwined with technology. While the top-line and bottom-line figures were relatively flat during FY24 and FY25, the phenomenal financial leap in FY26 makes the valuation appear aggressive if based solely on historical averages, but reasonably priced if the new growth momentum is sustained.

Conclusion: Investors with a higher risk appetite and a long-term investment horizon might find value in this technology-enabled logistics play. The substantial capital infusion towards working capital and subsidiary expansion is a positive indicator for future scalability. However, due diligence regarding the sustainability of the FY26 profit margins is highly recommended before parking substantial funds.

Registrar and Company Contact Information

For allotment status, refund queries, and company communications, investors can use the following details:

Lead Manager

Hem Securities Ltd.

Acts as the book running lead manager overseeing the public issue process.

Registrar to the Issue

Kfin Technologies Ltd.

Phone: 040-79615565

Email: credentconnect.ipo@kfintech.com

Company Details

Credent Connect N Care Ltd.

B-3, Second Floor, Nimri Commercial Complex,
Ashok Vihar, Phase-4, New Delhi, 110052

Phone: +91-9971777199

Email: cs@c3logistics.co.in

August 15, 2026

Fascinate Textiles

Fascinate Textiles IPO: Comprehensive Analysis and Details

Fascinate Textiles IPO Complete Guide: Is It Worth Your Investment?

Welcome to Publiclisting.in! Today, we bring you an in-depth analysis of the upcoming public issue from the apparel manufacturing sector. Fascinate Textiles Ltd. is gearing up to launch its SME initial public offering, aiming to raise capital for operational expansion and debt management. Let us explore the company’s business model, financial health, offering details, and market potential to help you make an informed decision.

Business Overview: What Does Fascinate Textiles Do?

Established in February 2017, Fascinate Textiles Ltd. specializes in producing a diverse array of ready-made apparel. While they cater to men, women, and children, their primary market dominance lies in children’s clothing. Their product catalog features everyday essentials such as t-shirts, joggers, leggings, vests, shorts, and exclusive infant wear tailored for various age demographics.

Operating from a centralized manufacturing unit situated in Barasat, West Bengal, the company oversees end-to-end production operations. As an ISO 9001:2015 certified entity, they strictly adhere to stringent quality management protocols. Currently, the company maintains a robust workforce of 254 individuals, combining permanent staff and contractual employees.

Core IPO Statistics & Details

The company plans to raise approximately ₹64.83 Crores through a book-built issue structure. This encompasses a fresh issuance of equity shares alongside an Offer for Sale (OFS) by the promoting entity. Below is a structured breakdown of the offering’s critical metrics.

Parameter	Detail
Issue Type	Book Building SME IPO
Listing Exchange	NSE SME
Total Issue Size	₹64.83 Crores (42,93,600 shares)
Fresh Issue	₹52.21 Crores
Offer for Sale (OFS)	₹12.62 Crores
Price Band	₹142 to ₹151 per equity share
Face Value	₹10 per share
Retail Application Lot	800 Shares

Timeline & Schedule: Track the Offering

Staying updated with crucial dates is vital for timely applications and tracking listing performance. Below is the chronological progression of the issue.

Bid Opens

Aug 11, 2026

Bid Closes

Aug 19, 2026

Basis of Allotment

Aug 20, 2026

Shares Credited

Aug 21, 2026

Market Listing

Aug 24, 2026

Investment Lot Configurations

To participate, investors must bid in designated lot multiples. The structure ensures opportunities across retail and High Net-worth Individual (HNI) categories.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at Upper Band)
Retail Investors	2 Lots (Minimum)	1,600 Shares	₹2,41,600
Small HNI (S-HNI)	3 Lots	2,400 Shares	₹3,62,400
Small HNI (Max)	8 Lots	6,400 Shares	₹9,66,400
Big HNI (B-HNI)	9 Lots	7,200 Shares	₹10,87,200

Financial Health & Track Record

A closer look at the financial books reveals an extraordinary growth trajectory over the past three fiscal years. Revenue has seen a steep climb, and profitability has surged significantly, prompting market observers to closely evaluate the sustainability of these margins.

Financial Metric (₹ in Crores)	FY Ending Mar 2024	FY Ending Mar 2025	FY Ending Mar 2026
Total Assets	25.45	42.26	92.75
Total Revenue	28.90	60.28	117.23
Profit After Tax (PAT)	0.48	5.81	15.07
Total Borrowings (Debt)	12.33	18.21	26.02
Net Worth	4.45	10.45	31.44

Key Performance Indicators (As of FY26)

Return on Equity (ROE): 72.08%
Return on Capital Employed (ROCE): 54.82%
Debt-to-Equity Ratio: 0.83
EBITDA Margin: 20.50%
Net Asset Value (NAV): 30.52

Capital Allocation Objectives

The net proceeds harvested from the fresh capital issuance are strategically earmarked for several operational milestones:

₹12.40 Crores: Funding capital expenditure for establishing an additional production facility to scale capacity.
₹19.03 Crores: Satisfying expanding working capital requirements to sustain regular operations smoothly.
₹2.68 Crores: Prepayment or scheduled repayment of existing secured and unsecured borrowings to optimize the balance sheet.
The remaining funds will be channeled towards general corporate purposes and issue-related expenditures.

Promoter Holding & Shareholding Pattern

The enterprise is spearheaded by a leadership group including Vishal Nahar, Chirag Ahuja, Rishabh Nahar, and Narinder Kumar Ahuja. Neetu Nahar will be participating as the selling shareholder via the OFS route.

Holding Category	Pre-Issue Stake	Post-Issue Stake
Promoters & Promoter Group	99.46%	68.40%
Public Ownership	0.54%	31.60%

Strengths & Weaknesses (SWOT Analysis)

Before making an investment commitment, it is essential to weigh the internal and external factors influencing the business ecosystem.

Strengths

Integrated in-house manufacturing process ensuring quality control.
Diverse product portfolio catering to multiple demographics.
Established relationships with long-term clientele.

Weaknesses

Sudden exponential jump in recent profitability may be difficult to sustain.
Increasing dependency on borrowed funds (rising debt figures).

Opportunities

Capacity expansion could tap into the booming domestic retail apparel market.
Potential to leverage modern e-commerce channels for direct-to-consumer sales.

Threats

Highly fragmented and competitive textile industry.
Vulnerability to raw material (cotton, yarn) price volatility.

Key Intermediaries & Contact Details

For application inquiries, allotment status checks, and corporate communications, refer to the details below:

Entity	Information
Lead Manager	Affinity Global Capital Market Pvt. Ltd.
Registrar to the Issue	Cameo Corporate Services Ltd. (Email: investor@cameoindia.com)
Market Maker	Giriraj Stock Broking Pvt. Ltd.
Company Registered Office	3/A Kutul Sahi Road, Barasat, Kolkata, West Bengal – 700124

Final Thoughts

The Fascinate Textiles IPO presents an interesting proposition within the apparel sector, highlighted by an aggressive growth sprint over recent fiscal years and strong fundamental metrics like ROE and ROCE. However, the textile domain remains heavily competitive, and the recent spike in net profits requires careful evaluation regarding long-term consistency. As always, align this opportunity with your risk tolerance, liquidity needs, and overarching portfolio strategy.

August 15, 2026

Shiprocket

Shiprocket IPO (2026): In-Depth Analysis & Investor Guide

Shiprocket IPO (2026): A Comprehensive Guide to India’s E-commerce Logistics Giant

The highly anticipated Shiprocket IPO is set to make its debut in the Indian stock market, opening an exciting window for investors looking to capitalize on India’s booming digital commerce landscape. Backed by cutting-edge technology and a massive distribution network, Shiprocket has revolutionized the way direct-to-consumer (D2C) brands and micro, small, and medium enterprises (MSMEs) operate.

This comprehensive blog post by Publiclisting.in breaks down everything you need to know before making an investment decision. From core business operations and valuation metrics to deep financial analysis and a complete SWOT breakdown, we have got you covered.

Understanding Shiprocket: What Does the Company Do?

Founded in 2011, Shiprocket has rapidly grown into India’s largest new-age, end-to-end e-commerce enablement platform (by revenue as of FY25). What started as a basic shipping software solution has now blossomed into a massive logistics and tech ecosystem tailored for MSMEs, large retailers, and D2C brands.

Core Services & Business Segments:

Domestic & International Shipping: Seamless shipping operations with instant pickups, secure delivery, weight verification, and quick Cash-on-Delivery (COD) settlements. They serve customers across 146 countries utilizing five major global shipping lanes.
Cargo & Fulfillment: Comprehensive warehousing, heavy logistics, and omnichannel commerce solutions via “Shiprocket Omuni”.
Merchant Solutions: A suite of emerging tech solutions designed to boost customer conversion, manage checkout processes, provide business loans, and offer marketing tools to scale merchant revenues.

Shiprocket IPO Essentials

The Shiprocket offering is a book-built issue looking to raise approximately ₹1,617.48 Crores. This capital raise is structured as a mix of a fresh issue of shares and an Offer for Sale (OFS) by existing shareholders.

IPO Attribute	Detail
Total Issue Size	₹1,617.48 Crores (16,67,61,566 shares)
Fresh Issue	₹885.50 Crores (9,12,99,203 shares)
Offer for Sale (OFS)	₹731.98 Crores (7,54,62,363 shares)
Price Band	₹92 to ₹97 per equity share
Face Value	₹10 per share
Employee Discount	₹9.00 per share
Listing Exchanges	BSE & NSE
Issue Type	Bookbuilding IPO

IPO Timeline & Implementation Schedule

Timing is critical when participating in public offerings. Below is the tentative timeline tracking the Shiprocket IPO from its opening day through to market listing.

IPO OpensAug 12, 2026

IPO ClosesAug 14, 2026

AllotmentAug 17, 2026

Refunds/CreditAug 18, 2026

ListingAug 19, 2026

Event	Tentative Date
Bid Opening Date	Wednesday, August 12, 2026
Bid Closing Date	Friday, August 14, 2026
Basis of Allotment Finalization	Monday, August 17, 2026
Initiation of Refunds & Demat Credit	Tuesday, August 18, 2026
Target Listing Date	Wednesday, August 19, 2026

Strategic Objectives: Where Will the Money Go?

Understanding how management intends to deploy the raised capital gives deep insights into the company’s future growth strategy. The net proceeds from the fresh issue (amounting to an estimated ₹941.20 Cr total planned usage) will be utilized for:

₹365.60 Cr: Enhancing Shiprocket’s platforms and marketing initiatives for their Emerging and Core Businesses.
₹205.80 Cr: Additional investment in targeted marketing initiatives to drive brand acquisition.
₹159.80 Cr: Strengthening technology infrastructure and system capabilities.
₹210.00 Cr: Debt reduction through partial or full prepayment of outstanding borrowings.
Remaining Funds: Financing inorganic growth through future strategic acquisitions and general corporate expenses.

Investment Categories and Lot Sizes

The offering caters to multiple investor categories with specific allocation limits. Qualified Institutional Buyers (QIB) take up 75% of the net issue, Non-Institutional Investors (NII/HNI) get 15%, and Retail Individual Investors are allocated the remaining 10%.

Investor Category	Minimum Lots	Minimum Shares	Investment Amount (At Upper Band)
Retail (Minimum)	1 Lot	154 Shares	₹14,938
Retail (Maximum)	13 Lots	2,002 Shares	₹1,94,194
S-HNI (Minimum)	14 Lots	2,156 Shares	₹2,09,132
S-HNI (Maximum)	66 Lots	10,164 Shares	₹9,85,908
B-HNI (Minimum)	67 Lots	10,318 Shares	₹10,00,846

Anchor Investor Insights

Ahead of the public subscription, Shiprocket successfully raised ₹727.42 Crores from anchor investors on August 11, 2026. A total of 7,49,91,568 shares were offered to these institutional buyers. The lock-in periods for these anchor investments are structured strictly: 50% of the shares will end their 30-day lock-in on September 16, 2026, and the remaining shares will be unlocked after 90 days on November 15, 2026.

Company Financials: A Deep Dive

Examining Shiprocket’s restated consolidated financial performance reveals a dual narrative: impressive revenue expansion but ongoing struggles with profitability.

Financial Metric (₹ in Crores)	FY Ending March 31, 2024	FY Ending March 31, 2025	FY Ending March 31, 2026
Total Assets	2,051.22	2,308.62	2,504.77
Total Income (Revenue)	1,357.83	1,674.82	2,077.42
Profit After Tax (PAT)	-595.18	-74.45	-79.25
Net Worth	1,284.16	1,491.23	1,524.29
Total Borrowing	213.28	244.67	242.01

Financial Takeaway: While Total Income surged by an impressive 24% between FY25 and FY26, the company continues to operate at a net loss, with PAT dipping slightly by 6% to negative ₹79.25 Cr in the same period. The negative EBITDA margins suggest that cash burn remains a significant factor as the company prioritizes aggressive market capture and infrastructure growth.

Company Valuation at Issue Price

Given the negative earnings, traditional valuation metrics like the Price-to-Earnings (P/E) ratio are in negative territory (-77.6 pre-IPO). At the upper price band of ₹97 per share, the company is targeting a Post-IPO Market Capitalization of approximately ₹7,057.50 Crores. The pre-IPO Price-to-Book Value (P/BV) stands at roughly 4.05, factoring an estimated Net Asset Value (NAV) of 23.96.

SWOT Analysis of Shiprocket

Strengths

Market Leadership: A dominant force in India’s e-commerce enablement space, recognized as a top player by total revenue.
Comprehensive Tech Ecosystem: Not just a shipping aggregator; it provides AI-driven marketing, international customs support, and unified dashboard solutions.
Global Reach: Active in 146 countries spanning major global lanes.

Weaknesses

Unprofitability: Consistent negative bottom lines and negative Return on Net Worth (RoNW stands at -5.20% for FY26).
Dependency on Third-Party Carriers: The core business relies heavily on external courier and cargo partners, potentially exposing the company to uncontrollable service disruptions.

Opportunities

D2C Boom in India: India is experiencing an explosion of direct-to-consumer digital brands that desperately require plug-and-play logistics solutions.
Cross-Border E-commerce: Expansion of government initiatives supporting MSME exports can act as a massive catalyst for Shiprocket’s international shipping arm.

Threats

Intense Competition: The logistics tech space is highly fragmented, battling against both local startups and legacy logistics titans modernizing their tech stacks.
Pricing Pressures: Price sensitivity among small merchants could impact future margin expansions.

Promoter Holdings & Key Stakeholders

It is important to note that Shiprocket operates as a professionally managed, venture-backed enterprise with No Identifiable Promoter. The pre-issue and post-issue public shareholding stands at 100%.

The Offer for Sale (OFS) comprises several major corporate and individual stakeholders liquidating partial equity, including:

LR India Fund I SARL: ₹271.70 Cr
Tribe Capital III LLC: ₹120.00 Cr
Gautam Kapoor & Saahil Goel: ₹61.00 Cr each
Other prominent VC funds: MCP3 SPV LLC, AFOS LLC, Moore Strategic Ventures, and 500 Startups III LP.

Key Contact Information & Registrar Details

Company Address	Shiprocket Ltd., 416, Phase III, Udyog Vihar, Sector 20, Gurugram, Haryana, 122008
Official Website	shiprocket.in
IPO Registrar	Kfin Technologies Ltd.
Registrar Email	shiprocket.ipo@kfintech.com
Lead Managers	Axis Capital, BOFA Securities, JM Financial, Kotak Mahindra Capital

General Market Sentiment & Investment Perspective

Market consensus suggests that while Shiprocket has successfully carved out a specialized niche as an API-led, merchant-first logistics platform, it operates in a highly competitive sector. The top-line revenue shows a healthy compounding growth trajectory; however, the persistent net losses require a cautious approach.

Financial analysts believe that because the issue is priced with a negative P/E ratio, it leans more towards risk-tolerant investors. Those with surplus cash and a long-term vision regarding India’s e-commerce infrastructure development might find value here, though short-term listing gains remain speculative.

Final Verdict

The Shiprocket IPO represents a unique opportunity to invest in a major infrastructure pillar of India’s fast-growing digital economy. By solving complex supply-chain problems for MSMEs and D2C brands, the company has secured a significant economic moat. However, the lack of current profitability demands that investors carefully weigh their risk appetite against the company’s robust revenue growth and strategic tech expansions. Ensure you review your portfolio and consult with your financial advisor before bidding.

August 15, 2026

Behari Lal Engineering

Behari Lal Engineering IPO: In-Depth Analysis, Dates, and Financials

Comprehensive Guide to Behari Lal Engineering IPO: Everything You Need to Know

The primary market continues to present dynamic opportunities for investors, and the upcoming public issue of Behari Lal Engineering Ltd. is catching the attention of market participants. With a rich history dating back to 1995, the company has positioned itself as a robust player in the iron and steel manufacturing sector.

Whether you are a retail investor analyzing potential listing gains or a long-term value seeker evaluating core fundamentals, this comprehensive analysis will walk you through the company’s business operations, financial stability, IPO timeline, and strategic goals to help you make an informed decision.

Corporate Blueprint: What Does Behari Lal Engineering Do?

Operating out of Mandi Gobindgarh, Punjab, Behari Lal Engineering Ltd. is a recognized name in integrated iron and steel manufacturing. The company excels at providing customized engineering solutions designed for highly critical industrial applications.

Their expansive product portfolio caters to multiple sectors, including mining, aggregate crushing, power generation, and sugar manufacturing. The core manufacturing segments include:

Premium Metal Rolls: Manufactured across various grades such as graphitic steel, S.G. iron pearlitic, alloy cast steel, and alloy steel base adamite.
Heavy Engineering Castings: Producing industrial-grade castings ranging from 500 kg all the way up to 20 Metric Tonnes (MT).
Alloy Steel Products: A wide array of stainless, carbon, and alloy steel bars in multiple sections (flats, hex, rounds, round corner squares) sized between 6 mm and 230 mm.
Forging Ingots & Shafts: Essential raw materials utilized in both open-die and closed-die forging applications.

Demonstrating its market penetration, the company has served over 1,825 domestic and international clients as of March 2026. Prominent names in their client roster include Shyam Metallics and Energy, BMW Industries, Amba Shakti Industries, and Metso India. Furthermore, their solid order book stands at a healthy ₹1,785.69 million (as of May 2026).

Critical IPO Specifications & Structure

The Behari Lal Engineering public offer is a book-built issue aimed at raising ₹301.62 crores. This capital generation comprises a fresh equity issuance worth ₹93.00 crores alongside an Offer for Sale (OFS) of ₹208.62 crores by the promoters and selling shareholders.

Key Parameter	IPO Details
Issue Type	Book Built Issue (Mainboard)
Total Issue Size	1,05,83,158 shares (₹301.62 Cr)
Fresh Issue	32,63,157 shares (₹93.00 Cr)
Offer for Sale (OFS)	73,20,001 shares (₹208.62 Cr)
Price Band	₹271 to ₹285 per Equity Share
Face Value	₹10 per share
Listing Exchanges	BSE & NSE

Actionable Timeline: IPO Open to Listing Date

Tracking the pivotal dates is crucial for successful allotment planning and fund management. Below is the scheduled progress of the public issue:

Aug 12, 2026

Bidding Opens

Aug 14, 2026

Bidding Closes

Aug 17, 2026

Allotment Finalization

Aug 18, 2026

Refunds & Demat Credit

Aug 19, 2026

Market Listing

Minimum Investment Breakdown & Lot Size

Retail and Non-Institutional Investors (NIIs) must adhere to the specific lot sizes set by the company. For this issue, one lot comprises 52 shares.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at Upper Band)
Retail (Minimum)	1 Lot	52	₹14,820
Retail (Maximum)	13 Lots	676	₹1,92,660
Small HNI (Minimum)	14 Lots	728	₹2,07,480
Big HNI (Minimum)	68 Lots	3,536	₹10,07,760

Investor Category Reservations & Anchor Placements

The company has structured its offerings to balance institutional stability with retail participation. Notably, Behari Lal Engineering has already secured a significant amount of ₹90.49 crores from Anchor Investors via an anchor book placement that concluded on August 11, 2026.

Qualified Institutional Buyers (QIB): 46.99% of the net offer (Includes 31.80% reserved for Anchor Investors).
Non-Institutional Investors (NII/HNI): 15.90% of the net offer.
Retail Individual Investors (RII): 37.10% of the net offer.

A Deep Dive into Financial Performance

Analyzing historical financials is key to understanding corporate health. Between the fiscal year ending March 2025 and March 2026, the firm showcased a resilient revenue growth of 6%, while the Profit After Tax (PAT) surged impressively by 22%.

Financial Metric (₹ in Crores)	FY Ending Mar 31, 2026	FY Ending Mar 31, 2025	FY Ending Mar 31, 2024
Total Assets	367.87	295.98	262.08
Total Revenue/Income	546.52	516.30	449.96
Profit After Tax (PAT)	64.64	52.95	35.79
EBITDA	101.32	81.31	60.99
Net Worth	306.10	241.62	193.66
Total Borrowings	17.78	7.58	41.21

Crucial Key Performance Indicators (KPIs)

As of March 2026, the company boasts strong return metrics that underscore efficient management:

Return on Equity (ROE): 23.60%
Return on Capital Employed (ROCE): 27.11%
Debt-to-Equity Ratio: 0.06 (Indicating a highly favorable, low-debt structure)
PAT Margin: 12.10%
Price to Earnings (P/E) Ratio: 17.21x (Pre-IPO) / 18.65x (Post-IPO)

Strategic Utilization of IPO Proceeds (Objectives)

Capital generated from the fresh issue side of the IPO (approximately ₹63.61 crores designated for specific projects) will be channeled toward operational expansion and efficiency:

₹19.59 Crores: Procurement and installation of new machinery and equipment (including civil works) at Manufacturing Facility 1.
₹36.65 Crores: Capacity expansion through new machinery and civil work at Manufacturing Facility 2.
₹6.80 Crores Total: Investment in sustainable energy via the installation of roof-top solar panels at both facilities (₹3.40 Cr each).
₹0.57 Crores: Scheduled repayment or prepayment of specific outstanding corporate borrowings.
Remaining funds will be allocated toward General Corporate Purposes.

Management & Promoter Holding

The foundational leadership of the company comprises Parkash Chand Garg, Rajesh Garg, Dinesh Garg, Lovlish Garg, and Bhuvnesh Garg. Their skin in the game remains prominent even after the public issue.

Pre-IPO Promoter Holding: 88.51%
Post-IPO Promoter Holding: 70.84%

SWOT Analysis of Behari Lal Engineering

To provide a well-rounded perspective, market analysts frequently evaluate core strengths and external threats:

Strengths: A nearly three-decade legacy in the steel industry, heavily diversified product applications, strong relationships with blue-chip manufacturing clients, and excellent return ratios (ROCE > 27%).
Weaknesses: The business is capital-intensive and heavily reliant on the cyclical nature of the broader industrial and infrastructure sectors.
Opportunities: Shifting towards green energy (solar rooftops) will lower future operational costs. Expansion in machinery promises to meet the massive ₹1,785.69 million unexecuted order book efficiently.
Threats: The steel and iron sector faces immense competition from unorganized local players and large-scale metal giants. High volatility in raw material pricing can squeeze profit margins if not passed on to consumers quickly.

Official Contact & Lead Managers

For investors seeking official prospectuses or direct queries regarding allotment, the contact details are outlined below:

Registered Corporate Office	Village Salani, Amloh Road, Mandi Gobindgarh, Fatehgarh Sahib, Punjab – 147301
Contact Email	cs@beharilalgroup.co
Registrar to the Issue	MUFG Intime India Pvt. Ltd. (Email: beharilalengineering.ipo@in.mpms.mufg.com)
Lead Managers	Emkay Global Financial Services Ltd. & Systematix Corporate Services Ltd.

Final Thoughts for Investors

Behari Lal Engineering brings a fundamentally sound business model to the public market. With its steady revenue growth, commendable margin expansion, and a very low debt-to-equity ratio, the firm demonstrates strong fiscal discipline. Furthermore, its planned capital expenditure towards capacity expansion and renewable energy suggests a forward-looking management approach focused on scaling sustainably.

However, as with any equity market investment, prospective investors must weigh these robust financials against macroeconomic factors affecting the steel industry. Assessing risk appetite and maintaining a balanced portfolio strategy is highly recommended when bidding for primary market issuances.

August 15, 2026

Pramodini Medicare

Pramodini Medicare IPO: Complete Analysis, Dates, Financials, and Review

The healthcare and diagnostic sector in India has witnessed monumental growth over the past decade, driven by increasing awareness and the necessity for accurate medical testing. Emerging as a notable player in this segment, Pramodini Medicare Limited is all set to enter the public market with its Initial Public Offering (IPO). This blog post offers an in-depth, data-backed overview of the Pramodini Medicare IPO, encompassing crucial dates, financial health, valuation, and a strategic market review to help you make an informed financial decision.

About Pramodini Medicare Limited

Established in the year 2000, Pramodini Medicare Limited has solidified its position as a reliable diagnostic service provider across India. Leveraging modern technology, the company delivers a broad spectrum of diagnostic solutions spanning radiology, clinical laboratories, and nuclear medicine.

The company caters to a diverse clientele including government hospitals, private healthcare institutions, medical colleges, and individual patients. As of mid-2026, the firm successfully operates 16 diagnostic centers spread out across seven Indian states, supported by a dedicated workforce of over 160 employees.

Core Business Models:

Public-Private Partnerships (PPP): Managing diagnostic facilities within government hospitals and medical educational institutions through long-term memorandums of understanding.
Private-Private Partnerships: Setting up and running specialized diagnostic wings inside private hospital establishments.
PSU Strategic Collaborations: Partnering with Public Sector Undertakings to manage diagnostic and imaging centers nationwide.
Standalone Diagnostic Clinics: Operating fully independent diagnostic laboratories serving direct walk-in patients and localized clinics.

Pramodini Medicare IPO Details

This upcoming public issue is a combination of a fresh issue of shares and an Offer for Sale (OFS) from existing promoters. The SME IPO aims to raise capital primarily to bolster the company’s infrastructure and technological capabilities.

Particulars	Details
Issue Type	Book Built Issue
Total Issue Size	₹69.04 Crores (58,51,200 shares)
Fresh Issue Component	₹63.14 Crores
Offer For Sale (OFS)	₹5.90 Crores (5,00,400 shares)
Price Band	₹110 to ₹118 per equity share
Face Value	₹10 per share
Listing Platform	NSE SME

Important IPO Dates & Timeline

Tracking the timeline is vital for seamless application and fund management. Below is the scheduled trajectory from the opening date to the market listing.

IPO Opens

Aug 12, 2026

IPO Closes

Aug 14, 2026

Basis of Allotment

Aug 17, 2026

Refunds Initiation

Aug 18, 2026

Demat Credit

Aug 18, 2026

Listing Date

Aug 19, 2026

Investment Lot Size Limits

To participate in this offering, retail and High Net-worth Individuals (HNIs) must adhere to the prescribed lot sizes. A single lot constitutes 1,200 shares.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at ₹118)
Retail Individual (Min/Max)	2 Lots	2,400 Shares	₹2,83,200
S-HNI (Min)	3 Lots	3,600 Shares	₹4,24,800
S-HNI (Max)	7 Lots	8,400 Shares	₹9,91,200
B-HNI (Min)	8 Lots	9,600 Shares	₹11,32,800

Company Financial Performance

A closer look at the financial trajectory of Pramodini Medicare highlights an impressive upward trend. Between the financial years concluding March 31, 2025, and March 31, 2026, the company reported a stellar 64% surge in revenue, complemented by a 56% growth in Profit After Tax (PAT).

Financial Metric (in ₹ Crores)	FY Ended Mar 31, 2024	FY Ended Mar 31, 2025	FY Ended Mar 31, 2026
Total Assets	48.78	56.45	93.62
Total Income	35.79	38.55	63.38
Profit After Tax (PAT)	7.14	11.14	17.38
Net Worth	24.75	35.77	53.15
Total Borrowing	11.96	10.81	17.85

Key Performance Indicators (KPIs) & Valuation

Evaluating the KPIs gives a clear picture of the management’s efficiency in utilizing resources. The robust Return on Equity (ROE) and healthy margins signify operational excellence.

ROE (Return on Equity): 39.08%
ROCE (Return on Capital Employed): 34.66%
Debt to Equity Ratio: 0.34 (indicates a highly manageable debt profile)
PAT Margin: 27.90%
Pre-IPO EPS: ₹10.41 | Post-IPO EPS: ₹7.88
Post-IPO Price-to-Earnings (P/E) Ratio: Approx. 14.97x
Market Capitalization at Upper Band: ₹260.14 Crores

Objectives of the IPO

The management plans to channel the net proceeds raised from the fresh issue into productive avenues to drive the next phase of corporate growth:

Capital Expenditure (₹45.15 Crores): Procurement of advanced medical equipment for upgrading existing centers and establishing new diagnostic hubs.
General Corporate Purposes: Utilizing the remaining funds for operational liquidity, identifying strategic inorganic acquisitions, and covering standard corporate expenses.

Promoter Holding & Anchor Investors

The company is promoted by Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar, and Sri Ram Medicare Pvt. Ltd. Prior to the public offering, the promoter group holds an 85.71% stake. Post-listing, their shareholding will dilute to a balanced 62.64%, allowing significant public participation.

Demonstrating institutional confidence, the company successfully raised ₹16.06 Crores from anchor investors on August 11, 2026, allocating a total of 13,60,800 shares with standard regulatory lock-in periods applied.

SWOT Analysis of Pramodini Medicare

Strengths

Diverse business models (PPP, PSUs, Standalone).
Consistent year-on-year financial and margin growth.
Experienced leadership and robust IT infrastructure.

Weaknesses

High capital dependency for purchasing imported medical equipment.
Potential vulnerability to regional market disruptions in operational states.

Opportunities

Growing awareness regarding preventive healthcare in Tier-II & Tier-III cities.
Expansion potential through strategic inorganic acquisitions.

Threats

Intense competition from organized diagnostic chains and local unorganized labs.
Fast-paced technological obsolescence requiring frequent equipment upgrades.

General Market Review and Sentiment

Market Outlook: Operating in a highly fragmented yet rapidly expanding diagnostic sector, Pramodini Medicare has showcased stellar top-line and bottom-line growth over recent fiscals. The impressive margins and sound fundamental metrics make it a visually attractive business model.

However, market analysts note that sustaining such aggressive outperformance in a fiercely competitive environment could be challenging. The issue is considered aggressively priced, factoring in near-term future earnings. Therefore, market sentiment suggests that cash-surplus investors with a long-term investment horizon and an appetite for moderate risk may consider allocating funds to this offering.

Registrar and Lead Management Info

For application-related queries, allotment status, or demat account credits, investors can reach out to the official registrar:

Registrar: Purva Sharegistry (India) Pvt. Ltd.
Email Support: newissue@purvashare.com
Book Running Lead Manager: Smart Horizon Capital Advisors Pvt. Ltd.

Conclusion

The Pramodini Medicare IPO opens doors for investors to buy into a technologically equipped, fast-growing diagnostic chain with a proven operational track record. While the company’s financial metrics reflect high profitability and manageable debt, investors should carefully weigh the competitive nature of the healthcare sector and the current valuation multiples before committing capital. Proper due diligence and portfolio alignment are strongly recommended.

Disclaimer: The analysis and data provided above are for educational and informational purposes only. It does not constitute financial or investment advice. Investors should consult their certified financial advisors before making any investment decisions.

August 15, 2026

Q&T Foods

Q&T Foods SME IPO 2026: Comprehensive Review and Market Potential

Comprehensive Review of Q&T Foods SME IPO 2026: Dates, Financials, and Market Potential

The Fast-Moving Consumer Goods (FMCG) sector, particularly the bakery segment, continues to demonstrate robust resilience and steady growth. Capitalizing on this consumer demand, Q&T Foods Limited is stepping into the public market space to raise capital and fuel its expansion. If you are tracking upcoming SME listings, this fixed-price issue requires careful evaluation.

In this detailed analysis, we will break down Q&T Foods’ business model, financial health, offering details, valuation metrics, and a strategic SWOT analysis to help you make an informed observation regarding their upcoming 2026 IPO.

1. Understanding Q&T Foods Limited: Business Overview

Established in 2018, Q&T Foods Limited has rapidly carved out a niche in the regional bakery industry. Operating primarily under their flagship brand “American Bakers”, the company manages the complete lifecycle of their products—from manufacturing to marketing and retail distribution.

Product Portfolio: Their diverse range includes everyday staples such as Milk Bread, Brown Bread, Multigrain Bread, and White Bread, alongside specialty items like Burger Buns, Pav, Kulchas, and Pizza Bases.
Manufacturing Prowess: Production takes place at an integrated 10,750 sq. ft. facility located in Ghaziabad, Uttar Pradesh. Notably, this facility adheres to strict global standards, holding both ISO 22000:2018 and HACCP certifications, with an impressive installed capacity of 9,472 Tonnes Per Annum (TPA).
Distribution Network: They have established a robust supply chain comprising over 50 dedicated dealers catering to retail outlets and local consumers across Uttar Pradesh and neighboring regions.

2. Core Details of the Initial Public Offering

The company plans to raise ₹26.25 Crores through a complete fresh issue of shares, with no Offer For Sale (OFS) component. This means all funds raised (post issue expenses) will be directed into the company’s growth rather than paying out existing shareholders.

Parameter	Offering Details
Issue Type	Fixed Price Issue (SME)
Face Value	₹10 per equity share
Issue Price	₹115 per share
Total Issue Size	22,82,400 shares (Aggregating up to ₹26.25 Cr)
Fresh Issue	100% (22,82,400 shares)
Market Maker Reservation	1,15,200 shares
Listing Exchange	BSE SME platform

3. Important Dates & IPO Schedule

Tracking the subscription and listing dates is crucial for timely execution. The public bidding window will be open for three days.

Issue Opens

Aug 12, 2026

Issue Closes

Aug 14, 2026

Allotment Finalized

Aug 17, 2026

Refunds & Demat Credit

Aug 18, 2026

Market Listing

Aug 19, 2026

4. Investment Requirements (Lot Sizes)

As this is an SME listing, retail participation requires a higher minimum capital outlay compared to mainboard listings. Bids must be placed in multiples of the stipulated lot size.

Investor Category	Minimum Lots	Total Shares	Investment Amount
Retail Individual Investor	2 Lots	2,400	₹2,76,000
High Net Worth Individual (HNI)	3 Lots	3,600	₹4,14,000

Note: The base lot size is mathematically 1,200 shares, but the mandated minimum application for retail investors stands at 2,400 shares (2 lots).

5. Capital Utilization Objectives

Transparency regarding the deployment of raised capital is a vital indicator of management intent. Q&T Foods intends to deploy the net proceeds across four major avenues:

Working Capital (₹7.50 Cr): To ensure smooth daily operations and inventory management.
Debt Reduction (₹6.75 Cr): Full or partial repayment of existing borrowings, which should lower finance costs and improve future profitability margins.
Capital Expenditure (₹4.42 Cr): For the procurement and installation of new equipment and machinery to upgrade the existing facility.
General Corporate Purposes (₹3.92 Cr): To cover strategic initiatives and contingency requirements.

6. Financial Performance Tracking

Analyzing historical financials gives an insight into the company’s trajectory. Over the past three audited fiscal years, Q&T Foods has displayed consistent top-line and bottom-line growth.

Particulars (in ₹ Crore)	FY Ended Mar 2024	FY Ended Mar 2025	FY Ended Mar 2026
Total Assets	14.34	19.68	26.57
Total Revenue	40.22	46.83	54.78
Profit After Tax (PAT)	1.96	2.74	5.20
EBITDA	3.77	4.82	8.37
Total Net Worth	2.44	7.04	12.24
Total Borrowings	9.84	10.11	11.05

Observation: The company witnessed a steady 17% revenue jump from FY25 to FY26, while PAT saw an impressive leap, almost doubling over the same period.

7. Key Performance Indicators (KPIs) & Valuation

For value investors, the underlying margins and return ratios provide the truest picture of efficiency.

Metric	Figure (As of Mar 2026)
Return on Equity (ROE)	53.95%
Return on Capital Employed (ROCE)	70.88%
EBITDA Margin	15.27%
PAT Margin	9.49%
Post-IPO P/E Ratio	15.65x
Market Capitalization	₹81.40 Crore (At issue price)

8. Ownership & Promoter Structure

The leadership team driving the brand “American Bakers” includes Nishant Raj Gupta, Khushbu Varshney, Usha Gupta, and Rakesh Gupta.

Pre-Issue Promoter Holding: 91.28%
Post-Issue Promoter Holding: 61.85%

The dilution of approximately 29.4% aligns with standard SME listing practices, keeping the majority control firmly with the founding group post-allotment.

9. Strategic SWOT Analysis

Strengths

Fully integrated, in-house manufacturing facility.
Internationally recognized certifications (ISO 22000:2018 & HACCP).
Consistent financial growth with expanding EBITDA margins.

Weaknesses

Heavy reliance on regional markets (primarily Uttar Pradesh).
Dependence on third-party dealer networks rather than direct-to-consumer channels.

Opportunities

Proceeds allocated for debt reduction will ease working capital constraints.
Expansion into neighboring states through increased marketing efforts.
Introduction of premium and healthy bakery alternatives.

Threats

High volatility in raw material costs (flour, sugar, edible oils).
Fierce competition from giant FMCG conglomerates and local unorganized bakeries.

10. Registration and Intermediary Details

For any queries related to allotment, non-receipt of refunds, or demat credits, investors can contact the appointed registrar. Corporate Makers Capital Ltd. will act as the lead manager driving the book building process.

Company Contact

Q&T Foods Limited
1/361 SF, Vaishali,
Ghaziabad, Uttar Pradesh – 201010
Email: cs@qtfoods.in

Registrar to the Issue

Skyline Financial Services Pvt.Ltd.
Phone: 011-26812682
Email: ipo@skylinerta.com

Final Takeaway

Q&T Foods presents itself as a growing regional player in the FMCG space with impressive recent profit jumps and strong return metrics (ROE at 53.95%). The brand equity of “American Bakers”, combined with certified manufacturing capabilities, offers a solid foundation. The decision to use raised funds partly for debt repayment and capacity expansion is a practical strategic move.

However, potential investors must weigh these strengths against the competitive nature of the bakery industry and the company’s concentrated regional presence. As always, market participants should assess their risk appetite and portfolio allocation strategies before participating in SME listings.

Disclaimer: The information provided in this article is for educational and analytical purposes only. It does not constitute financial advice. Please consult with a registered financial advisor before making any investment decisions.

August 15, 2026

Milky Mist Dairy Food

Milky Mist Dairy Food IPO: In-Depth Analysis, Dates, and Financials

Milky Mist Dairy Food IPO: Complete Analysis, Dates, and Investment Guide

The Indian consumer market is witnessing rapid modernization, and the premium packaged dairy segment is at the forefront of this revolution. Taking a bold step into the public markets is Milky Mist Dairy Food Limited, one of India’s fastest-growing packaged food companies. With a robust product lineup and a massive valuation, the Milky Mist Dairy Food IPO has garnered significant attention from institutional and retail investors alike.

In this comprehensive guide, we will break down the company’s business model, evaluate its financial health, outline key IPO dates, and provide a detailed SWOT analysis to help you understand the core fundamentals of this highly anticipated offering.

Company Overview: What Does Milky Mist Do?

Incorporated in July 2014, Milky Mist Dairy Food Limited has established itself as a powerhouse in the South Indian dairy market and is rapidly expanding its footprint nationwide. The company focuses predominantly on premium, value-added dairy products rather than just raw liquid milk.

Diverse Portfolio: The company manufactures and markets cheese, paneer, butter, curd, ghee, yogurt, ice cream, UHT products, frozen foods, ready-to-eat (RTE), ready-to-cook (RTC) foods, and chocolates.
Brand Power: Products are sold under the flagship brand ‘Milky Mist’ alongside specialized sub-brands like SmartChef, Capella, Misty Lite, Briyas, and Asal.
Farm-to-Consumer Model: The company bypasses middlemen by directly sourcing milk from farmers. This raw material is processed in state-of-the-art, highly automated manufacturing facilities.
Logistics: Backed by an extensive multi-channel distribution network and an in-house cold-chain logistics system, Milky Mist ensures product freshness and quality upon delivery.

Key IPO Details and Structure

The Milky Mist IPO is a book-built issue looking to raise a total of ₹1,553.00 Crores. This sizable offering is a combination of a fresh issue of shares intended to inject capital into the business, alongside an Offer for Sale (OFS) from existing promoters.

Issue Parameter	Offering Details
Total Issue Size	₹1,553.00 Crores (11,09,43,193 shares)
Fresh Issue Size	₹1,428.00 Crores (10,20,14,623 shares)
Offer for Sale (OFS)	₹125.00 Crores (89,28,570 shares)
Price Band	₹133 to ₹140 per equity share
Face Value	₹2 per share
Employee Discount	₹13.00 per share for eligible employees
Listing Exchanges	BSE, NSE

IPO Timeline and Progress

Understanding the exact timeline is crucial for planning your capital allocation. Below is the scheduled journey for the Milky Mist IPO, from bidding to market debut.

Offering Schedule

Bidding Opens Aug 11, 2026

Bidding Closes Aug 13, 2026

Allotment Status Aug 14, 2026

Refunds/Credit Aug 17, 2026

Market Listing Aug 18, 2026

Lot Size and Investment Requirements

The company has structured the minimum application size to be accessible for retail investors while providing tiered slabs for High Net Worth Individuals (HNIs).

Investor Category	Minimum / Maximum Limit	Shares	Investment Amount (at Upper Band)
Retail Investor (RII)	Minimum (1 Lot)	107 Shares	₹14,980
Retail Investor (RII)	Maximum (13 Lots)	1,391 Shares	₹1,94,740
Small HNI (sNII)	Minimum (14 Lots)	1,498 Shares	₹2,09,720
Big HNI (bNII)	Minimum (67 Lots)	7,169 Shares	₹10,03,660

Subscription Demand & Anchor Investors

Prior to opening to the public, the Milky Mist IPO successfully raised ₹465.30 Crores from anchor investors on August 10, 2026. The public demand has been overwhelming. By the final day of bidding, the total issue was subscribed an impressive 59.08 times.

Qualified Institutional Buyers (QIB): 164.03 times subscribed.
Non-Institutional Investors (NII): 36.75 times subscribed.
Retail Individual Investors: 8.86 times subscribed.
Employee Quota: 13.15 times subscribed.

This stellar QIB subscription indicates strong institutional faith in the company’s long-term business trajectory.

Financial Performance Analysis

A look at the restated consolidated financials reveals a company experiencing aggressive growth. The transition from FY25 to FY26 highlights substantial leaps in revenue generation and profitability margins.

Financial Metric	Year Ended Mar 31, 2024	Year Ended Mar 31, 2025	Year Ended Mar 31, 2026
Total Assets	₹1,606.26 Cr	₹2,150.59 Cr	₹2,676.46 Cr
Total Revenue	₹1,826.86 Cr	₹2,354.79 Cr	₹3,145.01 Cr
Profit After Tax (PAT)	₹19.44 Cr	₹46.07 Cr	₹127.01 Cr
EBITDA	₹222.33 Cr	₹310.35 Cr	₹435.22 Cr
Total Borrowings	₹1,036.72 Cr	₹1,376.38 Cr	₹1,671.85 Cr

Financial Highlights: Between March 2025 and March 2026, Milky Mist saw its revenue surge by 34%, while its Profit After Tax (PAT) experienced an explosive growth of 176%. The Return on Net Worth (RoNW) stands at a highly efficient 33.60%.

Company Valuation Metrics

At the upper price band of ₹140, the market capitalization of the company post-issue will stand at approximately ₹10,777.81 Crores. Based on the FY26 earnings, the pre-IPO Price-to-Earnings (P/E) ratio is 73.68x, and the post-IPO P/E ratio stretches to 84.85x. While the valuation falls in the premium territory, it reflects the company’s aggressive growth rates and expanding margins in the FMCG sector.

Objectives of the Issue

The company plans to deploy the net proceeds from the fresh issue (₹1,428 Crores) in a strategic manner to fuel expansion and optimize the balance sheet:

Debt Reduction: ₹496.86 Crores will be utilized for the prepayment or repayment of existing corporate borrowings, easing interest burdens.
Infrastructure Modernization: ₹469.24 Crores will be directed toward capital expenditure for expanding and upgrading the Perundurai Manufacturing Facility.
Distribution Expansion: ₹155.31 Crores will fund the deployment of point-of-sale infrastructure, specifically visi-coolers, ice cream freezers, and chocolate coolers across retail networks.
Corporate Operations: The balance amount will be utilized for general corporate purposes and working capital requirements.

Promoter Holding and Structure

The company is steered by promoters Sathishkumar T and Anitha S. The leadership team’s skin-in-the-game remains robust even after raising substantial public funds.

Pre-Issue Promoter Shareholding: 93.00%
Post-Issue Promoter Shareholding: 79.51%

The dilution of roughly 13.49% allows adequate public float while keeping majority control firmly in the hands of the original founders.

SWOT Analysis of Milky Mist Dairy Food

Before making any financial commitment, it is essential to evaluate the company from a 360-degree perspective.

Strengths

Strong brand equity and recall in the premium value-added dairy segment.
Direct milk sourcing model that ensures quality and creates farmer loyalty.
Highly automated facilities and an extensive in-house cold-chain logistics network.

Weaknesses

High existing debt levels (Total borrowings at ₹1,671.85 Cr as of FY26).
Aggressive IPO pricing valuation leaves little room for short-term market errors.
Heavy geographical concentration of revenue in the Southern Indian markets.

Opportunities

Rising disposable income and shifting consumer preferences towards branded dairy items.
Massive runway for geographical expansion into Northern and Western Indian states.
Potential to scale the ready-to-eat (RTE) and ready-to-cook (RTC) product verticals.

Threats

Intense competition from regional cooperatives (like Amul, Nandini) and private FMCG giants.
Vulnerability to erratic climatic conditions affecting cattle health and raw milk yields.
Fluctuations in raw material procurement prices impacting gross margins.

Contact and Administrative Details

For investors seeking further documentation or wishing to address grievances regarding share allotments, the regulatory and company details are as follows:

Entity	Contact Information
Registered Office	Milky Mist Dairy Food Ltd., SF No. 43/1-4, Pattakaranpalayam, Perundurai, Erode, Tamil Nadu – 638057
Company Email	investor@milkymist.com
Registrar to the Issue	Kfin Technologies Ltd. Email: milky.ipo@kfintech.com Phone: 040-79615565
Lead Managers	JM Financial Ltd, Axis Capital Ltd, IIFL Capital Services Ltd.

Conclusion

The Milky Mist Dairy Food IPO presents an interesting proposition within the rapidly growing Indian FMCG and dairy sector. The company’s exceptional revenue growth, massive leap in PAT margins, and clear strategies for debt reduction and capacity expansion paint a picture of a robust, future-ready enterprise. The direct farm-to-table supply chain acts as a strong competitive moat.

However, investors must balance these impressive growth metrics against the premium valuation multiples and the inherent competitive risks in the dairy industry. The substantial subscription from Qualified Institutional Buyers suggests high confidence from the smart money camp, paving the way for what could be a closely watched listing event on the Indian bourses. As with all market offerings, assessing personal risk appetite and conducting thorough portfolio evaluations remain the cornerstones of prudent investing.

August 14, 2026

Sham Foam

Sham Foam IPO Analysis, Dates, Financials & Review – Publiclisting.in

Sham Foam IPO: Comprehensive Analysis, Dates, and Financial Review

The primary market is buzzing with upcoming SME offerings, and the Sham Foam IPO has caught the attention of market participants. Slated to list on the BSE SME platform, this fixed-price issue presents an opportunity for investors looking to diversify their portfolio in the home comfort and manufacturing sector. Let’s delve into an in-depth analysis of the company’s business model, financial health, subscription details, and core objectives.

Business Overview: What Does Sham Foam Ltd. Do?

Established in 2020, Sham Foam Ltd. has rapidly emerged as a prominent player in the production, distribution, and marketing of polyurethane foam (PU Foam), premium mattresses, and related home comfort accessories. Catering primarily to the domestic market, their diverse portfolio includes:

Consumer Products: High-quality mattresses, pillows, cushions, and furniture upholstery sold under proprietary brands like Featherfresh and Restivia.
Industrial Solutions: Industrial-grade PU foam supplied across multiple sectors including automotive, apparel, furniture, and sports goods.
Infrastructure: A state-of-the-art ISO 9001:2015 and BIS-certified manufacturing unit located in Ambala, Haryana, spanning over 2,04,460 sq. ft.
Production Capacity & Reach: An installed foam capacity of 15,000 TPA, with an active supply chain penetrating 13 Indian states.

Sham Foam IPO Vital Details

The Sham Foam IPO is purely a fresh equity issue designed to raise capital for the company’s ongoing expansion and operational needs. Below is the structured breakdown of the public issue parameters:

Key Parameter	Detail
Issue Type	Fixed Price SME IPO
Total Issue Size	₹40.48 Crores (31,14,000 Shares)
Fresh Issue Size	₹38.00 Crores (29,58,000 Shares – Net Offer)
Issue Price	₹130 per Equity Share
Face Value	₹10 per Share
Market Maker Reservation	1,56,000 Shares (₹2.00 Cr)
Listing Exchange	BSE SME

Important Dates & Listing Schedule

Tracking the critical dates of the IPO is essential for seamless fund allocation and allotment checking. The entire process from bidding to listing concludes within a highly streamlined timeline.

Allotment Finalized (75%)

Open: Aug 11, 2026 Close: Aug 13, 2026 Allotment: Aug 14, 2026 Refunds/Credit: Aug 17, 2026 Listing: Aug 18, 2026

Investor Categories & Lot Size Breakdown

Understanding the minimum investment criteria is crucial before applying. Retail and High Net Worth Individual (HNI) investors have distinct lot size requirements.

Investor Category	Minimum Lots	Total Shares	Investment Amount
Retail Individual Investor (IND)	2 Lots	2,000 Shares	₹2,60,000
Retail Maximum Limit	2 Lots	2,000 Shares	₹2,60,000
HNI / NII (Minimum)	3 Lots	3,000 Shares	₹3,90,000

Live Subscription Status (As of Day 3 Closing)

The public response to an IPO heavily dictates the post-listing market sentiment. The issue witnessed a moderate oversubscription from retail and non-institutional participants.

Investor Category	Shares Offered	Subscription Times (x)
Retail Investors	14,79,000	2.62x
Non-Institutional Investors (NII)	14,79,000	2.17x
Total Overall Subscription	29,58,000	2.40x

Financial Track Record (Proforma Consolidated)

A deep dive into the financials reveals significant top-line and bottom-line growth over the past three fiscal years, highlighting robust operational scale-up.

Financial Metric (₹ in Crores)	FY 2024 (Mar 31)	FY 2025 (Mar 31)	FY 2026 (Mar 31)
Total Assets	33.55	36.58	49.32
Total Revenue	73.89	81.62	92.39
Profit After Tax (PAT)	2.97	3.58	8.65
Net Worth	8.88	12.46	21.11
Total Borrowings	10.11	9.22	3.99

Key Performance Indicators (KPIs) & Valuation Metrics

Based on the latest financial reporting of FY26, the company boasts strong return ratios. Here is how the valuation metrics stack up:

Metric	Value (FY26)	Valuation Aspect	Details
Return on Equity (ROE)	51.53%	Pre-IPO EPS	₹10.33
ROCE	45.73%	Post-IPO EPS	₹7.53
Debt to Equity Ratio	0.19	Pre-IPO P/E Ratio	12.58x
EBITDA Margin	11.91%	Post-IPO P/E Ratio	17.26x
PAT Margin	9.37%	Market Cap (At Issue)	₹149.38 Cr

Note: Market analysts suggest that while the profit margins and ROE represent phenomenal recent growth, evaluating sustainability and peer valuations is essential for conservative investors.

Primary Objectives of the IPO

The management plans to strategically deploy the net proceeds of ₹35.01 Crores (excluding issue expenses) towards the following growth initiatives:

Capital Expenditure (₹14.72 Cr): Funding civil construction and acquiring advanced machinery for upgrading the existing manufacturing facility.
Working Capital (₹14.25 Cr): Supporting day-to-day operational liquidity to manage inventory and scale production smoothly.
General Corporate Purposes (₹6.04 Cr): Facilitating unforeseen expenses and overarching corporate initiatives.

Promoter Leadership & Shareholding Pattern

The company is guided by experienced promoters: Rajinder Kumar Jindal, Sanjeev Kumar Jindal, Monica Jindal, Deepika Jindal, Abhinav Jindal, Kunal Jindal, and Charming Fashions Pvt. Ltd. Their strong leadership is reflected in their stake retention.

Pre-IPO Promoter Holding: 100.00%
Post-IPO Promoter Holding: 72.90%
Public Shareholding Post-IPO: 27.10%

Comprehensive SWOT Analysis

Strengths: Vertically integrated in-house manufacturing, robust pan-India distribution channels, reduction in total debt over the past three years.
Weaknesses: Aggressive pricing strategy relative to historical industry standards; susceptible to changes in raw material availability.
Opportunities: The rising middle-class demographic in India driving higher demand for premium sleep and home comfort products.
Threats: High competition from unorganized sector players and established branded mattress manufacturers in the domestic market.

Registrar and Corporate Information

IPO Registrar Details

Alankit Assignments Ltd.

Phone: 011-42541234 / 23541234

Email: info@alankit.com

Website: ipo.alankit.com

(Use the registrar portal to check final basis of allotment status).

Company Contact Information

Sham Foam Ltd.

Address: Khasra No. 18/16/2, Shahzadpur Yamunanager Road, NH-344, Village Rajpura, Ambala, Haryana, 134202

Phone: +91-8572071526

Email: info@shamfoam.com

Final Takeaway

The Sham Foam SME IPO introduces a fast-growing entity within the consumer and industrial polyurethane foam sector. With an impressive jump in FY26 profitability, significant reduction in borrowings, and a clear roadmap for capital deployment, the company poses an interesting proposition. However, potential stakeholders must weigh these impressive figures against the premium valuation asked at the fixed price of ₹130 per share. Always align your investment strategy with your personal risk appetite and long-term financial goals.

Disclaimer: This blog post is designed for educational and informational purposes only. It does not constitute financial advice. Investors should consult with a certified financial advisor before making any investment decisions.
© Publiclisting.in

August 14, 2026

Molbio Diagnostics

Molbio Diagnostics IPO Details, Valuation, and Subscription Analysis

Complete Analysis of Molbio Diagnostics IPO: Should You Invest?

The healthcare and diagnostics sector continues to capture significant investor attention as the demand for accurate, rapid, and accessible disease detection grows globally. In this highly anticipated public market debut, Molbio Diagnostics Limited brings its innovative technological footprint to the Indian stock market. This comprehensive guide breaks down all the crucial data, financials, subscription metrics, and strategic insights surrounding the Molbio Diagnostics IPO.

Who is Molbio Diagnostics?

Established in 2000, Molbio Diagnostics operates at the cutting edge of global point-of-care (POC) molecular diagnostics. The company’s defining achievement is its proprietary Truenat platform—a revolutionary, portable, and battery-operated PCR molecular diagnostics system. Engineered specifically for resource-limited environments, it delivers highly accurate test results within a single hour.

Currently, the company provides testing solutions for more than 30 different diseases, operating through 43 distinct diagnostic assays. These cover critical health conditions including COVID-19, Tuberculosis (TB), HIV, Hepatitis B & C, and HPV. With six advanced manufacturing facilities spread across India, Molbio exports its life-saving technology to over 90 countries worldwide, securing steady demand from international healthcare organizations, government health bodies, and diagnostic laboratories.

Critical IPO Milestones & Timeline

To help you track your investment window efficiently, below is the finalized chronological schedule for the initial public offering. Be mindful of the crucial closing date to ensure timely bidding.

Bidding Opens

Aug 10, 2026

Bidding Closes

Aug 12, 2026

Basis of Allotment

Aug 13, 2026

Shares Credited

Aug 14, 2026

Market Listing

Aug 17, 2026

Core IPO Metrics & Structural Details

The total capital raised in this public issue stands at roughly ₹940 Crores, employing a book-built method. The issue blends a fresh issuance of equity alongside an Offer for Sale (OFS) from existing stakeholders.

Specification	Detail
Issue Size Total	₹939.70 Crores (1,16,46,246 Shares)
Fresh Capital Raise	₹200.00 Crores (24,80,246 Shares)
Offer for Sale (OFS)	₹739.70 Crores (91,66,000 Shares)
Final Price Band	₹768 to ₹807 per equity share
Face Value	₹1 per share
Exchange Listing	BSE & NSE
Employee Reservation Limit	Discount of ₹76.00 offered to eligible employees

Minimum Investment and Lot Sizes

The application structure is categorized across Retail, Small High Net Worth Individuals (S-HNI), and Big High Net Worth Individuals (B-HNI). A single lot mandates 18 shares.

Investor Category	Minimum Lots	Total Shares	Capital Required (₹)
Retail (Minimum)	1 Lot	18	₹14,526
Retail (Maximum)	13 Lots	234	₹1,88,838
S-HNI (Minimum)	14 Lots	252	₹2,03,364
S-HNI (Maximum)	68 Lots	1,224	₹9,87,768
B-HNI (Minimum)	69 Lots	1,242	₹1,002,294

Financial Health and Growth Trajectory

A consistent upward trajectory is visible in Molbio Diagnostics’ revenue and profitability figures over the past three fiscal cycles. From March 2024 to March 2026, the company successfully scaled operations, registering a robust 42% growth in revenue and an 18% surge in Profit After Tax (PAT) in the most recent fiscal year comparison.

Financial Metric (in ₹ Crore)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Total Assets	2,148.42	1,461.56	1,221.06
Total Income (Revenue)	1,455.17	1,027.94	840.66
EBITDA	328.24	256.64	185.09
Profit After Tax (PAT)	164.14	138.58	83.54
Overall Net Worth	1,144.68	952.95	807.94
Total Borrowings	412.64	123.16	174.58

Key Valuations

Earnings Per Share (EPS): ₹14.56 (Pre-IPO) / ₹14.24 (Post-IPO)
Price-to-Earnings (P/E) Ratio: 55.43x
Return on Net Worth (RoNW): 14.55%
Market Capitalization at Upper Band: Approximately ₹9,299.87 Crores post-listing.

Strategic Utilization of Fresh Issue Capital

The ₹200 crore generated via the fresh issue is slated to fundamentally strengthen the company’s long-term operational backbone. The management has delineated the following capital allocation strategy:

₹105.54 Crores: Earmarked for capital expenditure regarding the establishment of a state-of-the-art Research & Development facility, a Center of Excellence, and corresponding office infrastructures.
₹72.28 Crores: Allocated to procure critical plant, machinery, and equipment for manufacturing facilities across Goa and Visakhapatnam.
₹9.47 Crores: Channelled towards general corporate and administrative purposes.

Anchor Investor Participation and Subscription Metrics

Prior to opening the bid for the general public, Molbio Diagnostics locked in substantial capital from institutional sources. On August 7, 2026, the company successfully raised ₹281.46 crore by allocating 34,87,717 shares to leading anchor investors.

Subscription Overview: The market exhibited tremendous confidence in the company’s fundamentals. At market close on Day 3, the offering was oversubscribed by a massive 70.27 times. Institutional buyers led the momentum (QIBs oversubscribed 186.39x), followed by strong responses from Non-Institutional Investors (49.80x) and Retail participants (12.97x).

SWOT Analysis of Molbio Diagnostics

Strengths

Proprietary and WHO-endorsed Truenat molecular diagnostics platform.
Extensive global presence spanning across more than 90 countries.
Consistently robust financial growth and strong EBITDA margins.

Weaknesses

Significant dependence on government health schemes and institutional tenders.
Sudden increases in raw material costs can temporarily affect gross margins.

Opportunities

Untapped potential in developing nations seeking affordable healthcare.
Expansion of R&D can introduce novel testing assays for emerging viral diseases.
Strategic acquisitions to bolster their digital pathology presence.

Threats

Fierce competition from global healthcare and biotech giants.
Strict, ever-evolving international healthcare regulations and compliance demands.

Leadership & Shareholding Structure

The enterprise is directed by a highly experienced group of promoters: Sriram Natarajan, Chandrasekhar Bhaskaran Nair, Sangeetha Sriram, Shiva Sriram, Sowmya Sriram, and Exxora Trading LLP.

Shareholder Category	Pre-Issue Holding	Post-Issue Holding
Promoters & Promoter Group	44.89%	41.29%
Public & Others	55.11%	58.71%

Key Contact and Registrar Information

For inquiries regarding share allotment status, demat credit, or refunds, investors should communicate directly with the officially appointed registrar.

Entity	Details
Registered Office	Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa, 403722
Registrar to the Issue	Kfin Technologies Ltd.
Lead Managers	Kotak Mahindra Capital, IIFL Capital Services, Jefferies India, Motilal Oswal Investment Advisors

Concluding Market Sentiment

Market analysts observe that Molbio Diagnostics has cultivated a formidable global footprint rooted in modernized, proprietary healthcare technology. Their ability to deliver rapid results via the Truenat platform essentially places them in a niche of their own. While the P/E ratio indicates that the IPO is aggressively priced, the historical revenue and steady bottom-line growth present a highly scalable business model. Market sentiment leans positively toward the stock, emphasizing that investors looking at a medium to long-term horizon might find significant intrinsic value in adding a leading innovator in molecular diagnostics to their portfolio.

August 14, 2026

Dhoot Transmission

Dhoot Transmission IPO: In-Depth Analysis and Details

PublicListing.in

Comprehensive Guide to the Dhoot Transmission IPO: Dates, Financials, and Market Outlook

The Indian stock market is gearing up for a monumental public offering with the highly anticipated Dhoot Transmission IPO. As electric vehicles (EV) and automotive technologies continue to dominate market trends, companies supplying critical infrastructure to these sectors are capturing immense investor attention.

Valued at a staggering ₹3,066.89 Crores, this initial public offering aims to capitalize on the company’s robust market standing. Whether you are an institutional bidder or a retail investor looking for long-term growth potential, this detailed analysis provides all the crucial insights, from financial health and valuation metrics to subscription data and future growth objectives.

Understanding the Business: What Does Dhoot Transmission Do?

Established in 1998, Dhoot Transmission stands as a formidable powerhouse in India’s electrical and electronics manufacturing ecosystem. The company specializes in the end-to-end design, engineering, and production of sophisticated wiring harnesses and electrical distribution systems.

They cater to a broad spectrum of industries, heavily focusing on the automotive sector. Notably, Dhoot Transmission is recognized as one of the top two manufacturers in the Indian two-wheeler (2W) and three-wheeler (3W) wiring harness markets, commanding an impressive 41% market share.

More importantly, the company has successfully pivoted toward the future of mobility. As of recent metrics, they hold a commanding 70% market share in the electric 2W and 3W segments. With over 2,700 full-time employees and an operational framework spanning 23 established manufacturing plants, their portfolio encompasses battery packs, sensors, electronic controllers, and power supply cords optimized for both internal combustion engines (ICE) and EV platforms.

Strategic SWOT Analysis

To evaluate the intrinsic potential of the Dhoot Transmission public issue, a look into its strategic positioning is essential:

Strengths: Absolute dominance in the EV 2W and 3W wiring harness segment. Highly diversified client portfolio featuring top-tier Original Equipment Manufacturers (OEMs). Scalable manufacturing with 23 operational plants and robust R&D capabilities.
Weaknesses: Significant reliance on the cyclical automotive industry. Substantial outstanding borrowing, though part of the IPO proceeds aims to rectify this.
Opportunities: Rapid global and domestic transition towards Electric Vehicles. Rising demand for premium connected vehicles and automation, creating a larger addressable market for high-tech electronic controllers.
Threats: Intense raw material price volatility. Stiff competition from both domestic electronic manufacturers and international supply chains.

Core IPO Structure and Offer Details

The offering is a hybrid of a fresh issue and an Offer for Sale (OFS), designed to balance internal capital requirements with providing an exit strategy for existing promoters.

Particulars	Details
Total Issue Size	₹3,066.89 Crores (3,52,18,047 shares)
Fresh Capital Issue	₹1,400.00 Crores (1,60,80,445 shares)
Offer for Sale (OFS)	₹1,666.89 Crores (1,91,37,602 shares)
Price Band	₹829 to ₹871 per share
Face Value	₹2 per equity share
Listing Exchanges	BSE and NSE
Employee Discount	₹80.00 per share

Important Dates and Application Timeline

Tracking the public issue timeline is vital to ensure you do not miss the application or allotment window. Below is the scheduled progression of the offering.

Issue Opens Aug 10, 2026

Issue Closes Aug 12, 2026

Basis of Allotment Aug 13, 2026

Refunds/Credit Aug 14, 2026

Market Listing Aug 17, 2026

Investment Lot Sizes

Retail and High Net-worth Individuals (HNIs) are required to bid in specific lot sizes. The foundational lot size for this issue is set at 17 shares.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at Upper Price)
Retail (Minimum)	1 Lot	17	₹14,807
Retail (Maximum)	13 Lots	221	₹1,92,491
Small HNI (Minimum)	14 Lots	238	₹2,07,298
Big HNI (Minimum)	68 Lots	1,156	₹10,06,876

Financial Performance and Health

A compelling aspect of the company is its steady upward financial trajectory. The restated consolidated financials showcase impressive year-on-year growth, justifying the premium valuations demanded by the issue price.

Financial Metric (₹ in Crores)	FY 2024	FY 2025	FY 2026
Total Assets	1,711.70	2,336.23	4,114.83
Total Revenue	2,799.32	3,472.24	4,563.70
Profit After Tax (PAT)	298.75	353.89	396.84
Net Worth	741.01	978.18	2,397.15
Total Borrowing	554.90	776.06	841.39

Market Valuation Metrics

Understanding valuation helps ascertain if the stock is priced competitively against market peers. Post-issue metrics provide a clearer picture of shareholder value dilution.

Key Indicator	Pre-IPO	Post-IPO
Earnings Per Share (EPS)	₹21.06	₹19.40
Price to Earnings (P/E) Ratio	41.36x	44.90x
Return on Net Worth (RoNW)	16.55% (as of FY26)
Estimated Market Capitalization	₹17,816.14 Crores

Subscription Status (Closing Day Data)

Market enthusiasm was vividly reflected in the subscription numbers. The issue received an overwhelming response across all investor categories, concluding with a massive oversubscription.

Investor Segment	Subscription Times (x)
Qualified Institutional Buyers (QIB)	209.02x
Non-Institutional Investors (NII)	53.13x
Retail Individual Investors	8.32x
Employees	8.60x
Total Overall Subscription	75.06x

Primary Objectives of the Issue

The capital generated from the fresh issue segment (₹1,400 Crores) is meticulously planned to fortify the company’s balance sheet and expand its operational footprint:

Debt Reduction (₹464.80 Cr): Full or partial prepayment of outstanding corporate borrowings.
Subsidiary Support (₹301.77 Cr): Direct investments into subsidiaries (Dhoot Autocomponents, Dhoot Electricals, Dhoot Automotive, and Dhoot Transmission UK) to alleviate their respective debts.
Infrastructure Expansion (₹150.00 Cr): Establishment of brand new wiring harness manufacturing facilities located in Jhajjar (Haryana) and Hosur (Tamil Nadu).
Strategic Growth (₹410.41 Cr): Reserved for funding inorganic growth via undisclosed acquisitions and general corporate necessities.

Promoter Holding and Anchor Investments

The company is primarily driven by BC Asia Investments XV Ltd. and Rahul Radhavallabh Dhoot. Prior to the public offer, promoters held a 100% stake in the entity. Post-listing, to comply with public float regulations and facilitate the OFS, the promoter equity shareholding will stand at a solid 82.78%, indicating strong continued faith by the founders and primary backers.

Furthermore, the offering garnered exceptional trust from institutional giants during the Anchor bidding phase, successfully raising ₹918.27 Crores from anchor investors prior to the public opening.

Management, Registrars, and Contact Data

A syndicate of top-tier financial institutions managed the complexities of this massive book-built issue, including Axis Capital, Jefferies, Kotak Mahindra Capital, Nomura, SBI Capital Markets, and 360 One WAM.

Registrar Information

Kfin Technologies Ltd.

Phone: 040-79615565

Email: dhoot.ipo@kfintech.com

Company Headquarters

Dhoot Transmission Ltd.

Gut No 312, Nanekarwadi, Chakan,
Pune, Maharashtra – 410501

Phone: +91-24 3166 2600

Email: cs@dhoottransmission.com

Conclusion

The Dhoot Transmission public issue represents a pivotal moment in the automotive component space. With an ironclad grip on the 2-wheeler and 3-wheeler EV wiring harness market, expanding manufacturing capabilities, and a clear vision to reduce existing debt, the company positions itself as a forward-looking enterprise.

While the broader automotive sector is subject to cyclical fluctuations, the dedicated shift towards green mobility acts as a massive tailwind. Investors eyeing robust, technology-driven manufacturing entities may find this stock a compelling addition to their long-term portfolios, provided it aligns with their individual risk appetite and market strategies.

August 14, 2026